Nifty Pharma index hits 52-week high; Cipla, Sun Pharma touch 52-week highs

Nifty Pharma index hit a 52-week high of 10,142, rising 2%, in early morning deal, surpassing its previous high of 10,063 recorded on November 3, 2017 in intra-day trade on the NSE.

Shares of pharmaceutical companies extended their upward journey with the Nifty Pharma index hitting its 52-week high on the National Stock Exchange (NSE), on positive corporate announcements from Strides Pharma Science and Lupin.

At 09:44 am; Nifty Pharma index, the largest gainer among sectoral indices, was up 1.4% at 10,086 points, as compared to 0.14% rise in the Nifty 50 index. The index hit a 52-week high of 10,142, rising 2%, in early morning deal. It surpassed its previous high of 10,063 recorded on November 3, 2017 in intra-day trade.

Lupin, Cipla, Cadila Healthcare, Dr Reddy’s Laboratories, Aurobindo